Researchers are exploring ways to reprogram dendritic cells to overcome immune suppression caused by tumors. Studies are investigating the role of dendritic cells in the tumor microenvironment and how they can be targeted for immunotherapy. Various approaches, including metabolic reprogramming and immunometabolic rewiring, are being examined as potential strategies to enhance immune response and overcome resistance to immunotherapy in different types of cancer.